Merck

Yahoo Finance • 7 hours ago

Stock Market Today: Indexes End Lower; Moderna Dives On FDA Memo; Synopsys, Nvidia Jump (Live Coverage)

The Dow fell on the stock market today. Moderna skidded after an FDA memo linked Covid vaccines to deaths. A gold stock cleared an entry. Continue Reading View Comments... Full story

Yahoo Finance • 10 hours ago

Stock Market Today: Dow Down; Moderna Dives On FDA Vaccine Memo; Bitcoin Plays Flop (Live Coverage)

The Dow Jones index fell on the stock market today. Synopsys popped on an investment from AI giant Nvidia. A gold stock cleared an entry. Continue Reading View Comments... Full story

Yahoo Finance • 13 hours ago

UK and US agree zero tariff deal on pharmaceuticals

The UK has sealed a deal to give the US zero tariffs on pharmaceutical products imported into the country, in return for the NHS spending more on medicines. Import taxes on medicines and treatments will remain at 0% for three years, the U... Full story

Yahoo Finance • 14 hours ago

UK to pay 25% more for new drugs under deal with US

[Pile of different colourful pills placed next to 20 British pound banknotes.] Oleksandr Siedov An agreement in principle reached between UK and US trade negotiators will have the latter's National Health Service pay 25% higher list price... Full story

Yahoo Finance • 16 hours ago

MRK a Top 25 Dividend Giant With $41.48B Held By ETFs

Merck & Co Inc (Symbol: MRK) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $41.48B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 3.24% yield, according to th... Full story

Yahoo Finance • 17 hours ago

Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025

Merck granted Fast Track Designation by the U.S. FDA for MK-2214 for the treatment of Alzheimer's disease RAHWAY, N.J., December 01, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ann... Full story

Yahoo Finance • 18 hours ago

Buffer Preparation Market Trends & Forecasts Report 2025-2035 Featuring Asahi Kasei, Avantor, Canvax, Danaher, GE, HOPAX, Merck, Prepared Biologics, Sartorius, Sepragen, Thermo Fisher Scientific, ZETA

Company Logo Key opportunities in the buffer preparation market include expanding demand for advanced buffer systems in biopharma production, increasing preference for outsourcing to reduce costs, and growth potential in reusable equipmen... Full story

Yahoo Finance • yesterday

Wells Fargo Upgrades Merck (MRK) to Overweight, Raises Price Target to $125

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Boring Dividend Stocks to Buy.Wells Fargo Upgrades Merck (MRK) to Overweight, Raises Price Target to $125 Photo by Vitaly Taranov on Unsplash On November 24, Wells Fargo upgraded... Full story

Yahoo Finance • 2 days ago

Jim Cramer Says He is “Particularly Fond” of Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer discussed, along with the need for diversification. Cramer highlighted that he is fond of the stock, as he said: “You could own JNJ and Merck with their incredible franchises. Y... Full story

Yahoo Finance • 5 days ago

Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035

Company Logo The global follicular lymphoma market is witnessing growth due to advancements in targeted therapies and immunotherapies. Follicular lymphoma, an indolent form of non-Hodgkin lymphoma, often presents challenges like relapse a... Full story

Yahoo Finance • 5 days ago

How Analyst Views on Merck Are Evolving as Growth Prospects and Risks Shift

Merck has seen its fair value estimate edge higher to $104.27, up from $102.33, following recent updates to its growth outlook. Analysts cite an improved revenue growth expectation and a small uptick in the discount rate as drivers for thi... Full story

Yahoo Finance • 5 days ago

Why Merck (MRK) Is Up 9.6% After Pipeline Upgrade and Regulatory Wins and What's Next

In the past week, Merck received a boost as Wells Fargo upgraded its rating, citing increased confidence in Merck’s drug pipeline and noting significant progress in regulatory approvals for new oncology and HIV treatments. A key insight is... Full story

Yahoo Finance • 5 days ago

CMS unveils price reductions for 15 drugs for 2027

[Pills and money] txking/iStock via Getty Images Individuals covered under Medicare can expect significant savings on the 15 drugs that were selected earlier this year for drug price negotiations under the Inflation Reduction Act starting... Full story

Yahoo Finance • 6 days ago

Dow Movers: CRM, NVDA

In early trading on Tuesday, shares of NVIDIA topped the list of the day's best performing Dow Jones Industrial Average components, trading up 2.0%. Year to date, NVIDIA has lost about 0.3% of its value. And the worst performing Dow comp... Full story

Yahoo Finance • 6 days ago

Nanotechnology Drug Delivery Market Projected to Reach USD 200.77 Billion by 2032, Owing to Prevalence of Chronic Diseases & Advances in Nanomedicine – SNS Insider

Austin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nanotechnology Drug Delivery Market Size & Growth Analysis According to a SNS Insider, the Nanotechnology Drug Delivery Market size was valued at USD 96.39 billion in 2024 and is projected to re... Full story

Yahoo Finance • 6 days ago

Gene Therapy Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 787 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive listing of 787 gene therapy deals anno... Full story

Yahoo Finance • 6 days ago

Merck to Participate in the Citi 2025 Global Healthcare Conference

RAHWAY, N.J., November 26, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Chirfi Guindo, chief marketing officer, Human Health, and Dr. Eliav Barr, senior vice president... Full story

Yahoo Finance • 6 days ago

Merck Reaches Analyst Target Price

In recent trading, shares of Merck & Co Inc (Symbol: MRK) have crossed above the average analyst 12-month target price of $92.07, changing hands for $92.32/share. When a stock reaches the target an analyst has set, the analyst logically h... Full story

Yahoo Finance • 6 days ago

Stocks to Watch Wednesday: Dell, HP, Workday, Li Auto

↗️ Dell (DELL): The computer and software maker raised full-year guidance and forecast AI server shipments would more than double. Shares rose nearly 5% premarket. ↘️ HP (HPQ): The computer and printer maker plans to cut up to 10% of its w... Full story

Yahoo Finance • 6 days ago

Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices

The Centers for Medicare & Medicaid Services said Tuesday it expects to achieve net savings of 44%, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story